ArticleClinical kidney journal2025
Association of dietary carbohydrate intake with risk of mortality in maintenance hemodialysis patients: a multicenter prospective cohort study.
Article in Clinical kidney journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Current evidence on the relationship between dietary carbohydrate intake (DCI) and mortality risk among patients undergoing maintenance hemodialysis (MHD) is limited. Moreover, the joint impact of DCI and dietary energy intake (DEI) on mortality remains unclear. Therefore, we aimed to investigate both the individual and combined associations of DCI and DEI with all-cause and cardiovascular disease (CVD) mortality. Methods: This study included 1044 MHD patients from eight outpatient dialysis centers across China. The DCI, expressed as a percentage of carbohydrate intake in total energy intake, was determined via 24-h dietary recalls over 3 days. The study outcomes included all-cause and CVD mortality. Cox proportional hazard models were utilized to evaluate both the individual and combined associations of DCI and DEI with mortality risk. Results: During a median follow-up of 45.6 months, 352 deaths were recorded, of which 206 (58.5%) were due to CVD. When DCIs were assessed as quartiles, patients in the fourth quartile (≥72.1%) were associated with a greater risk of all-cause mortality [hazard ratio (HR) 2.16; 95% confidence interval (CI) 1.10, 4.25] than patients in the first quartile (<61.5%), whereas patients in the second quartile (61.5%-66.7%; HR 1.27; 95% CI 0.87, 1.87) and the third quartile (66.7%-72.1%; HR 1.40; 95% CI 0.84, 2.31) were not significantly different. A similar trend was found for CVD mortality. When analyzed jointly, patients with high DCIs (≥72.1%) and low DEIs (<25 kcal/kg/day) had the highest risk of all-cause and CVD mortality. Conclusions: A higher DCI was associated with a higher risk of all-cause and CVD mortality in MHD patients. Patients with high DCIs and low DEIs had a worse survival prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.